<

AFFLUENT MEDICAL Affluent Medical : 2022 financial communication calendar

Transparency directive : regulatory news

24/01/2022 17:45

Affluent Medical
Affluent Medical : 2022 financial communication calendar

24-Jan-2022 / 17:45 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


PRESS RELEASE

Aix-en-Provence, 24 January 2022 - 5:45 PM

 

 

 

2022 financial communication calendar

 

 

 

Affluent Medical (ISIN code: FR0013333077 - mnemonic: AFME), a French medtech specialised in the international development and industrialisation of innovative medical prostheses - at a clinical stage - to treat urinary incontinence and the pathology of the heart mitral valve, today is announcing its 2022 financial communication calendar.

 

 

  • Tuesday, March 29, 2022

Publication of financial statements as of December 31, 2021

  • Thursday, September 22, 2022

Publication of financial statements as of June 30, 2022

 

 

All communications are published after market close.

This schedule is provided for information purposes only and may change.

 

 

About Affluent Medical

Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the aim of becoming a global leader in the treatment of heart and vascular diseases, which are the leading cause of death worldwide, and of urinary incontinence, which today affects one in four adults. Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas. The four major technologies developed by the Company are currently in the preclinical and clinical study phase. The first medical device should be marketed in Europe with Kalios.

For more information, please visit: www.affluentmedical.com

 

 

Contacts:

AFFLUENT MEDICAL

Jérôme Geoffroy

Chief Financial Officer

investor@affluentmedical.com

ACTIFIN, financial communication

Ghislaine Gasparetto

+33 (0)6 21 10 49 24

affluentmedical@actifin.fr

ACTIFIN, financial press relations

Jennifer Jullia

+33 (0)6 47 97 54 87

jjullia@actifin.fr

 

DGM, corporate press relations

Thomas Roborel de Climens

+33 (0)6 14 50 15 84

thomasdeclimens@dgm-conseil.fr

 


Regulatory filing PDF file

File: 2022 financial communication calendar


Language: English
Company: Affluent Medical
320 avenue Archimède, Les pléiades III Bâtiment B
13100 Aix en Provence France
France
Phone: +33 4 42 95 12 20
E-mail: jerome.geoffroy@affluentmedical.com
Internet: https://www.affluentmedical.com/
ISIN: FR0013333077
Euronext Ticker: AFME
AMF Category: Inside information / Issuer activities (acquisitions, sales...)
EQS News ID: 1272179
 
End of Announcement EQS News Service

1272179  24-Jan-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1272179&application_name=news&site_id=symex


Other stories

19/05/2024 02:24
19/05/2024 00:50
18/05/2024 21:06
18/05/2024 19:02
18/05/2024 21:54
18/05/2024 18:31
18/05/2024 18:50
18/05/2024 23:51
18/05/2024 20:16
18/05/2024 23:20
19/05/2024 03:09
18/05/2024 20:42
19/05/2024 04:56
18/05/2024 23:53
19/05/2024 01:35
17/05/2024 17:26
18/05/2024 23:05
19/05/2024 02:05
18/05/2024 00:30
18/05/2024 06:15
17/05/2024 20:08
17/05/2024 15:07
18/05/2024 21:01
18/05/2024 20:57
19/05/2024 02:09
18/05/2024 21:00
19/05/2024 06:05
19/05/2024 00:23
18/05/2024 22:22
18/05/2024 21:00
17/05/2024 15:34
18/05/2024 19:33
18/05/2024 16:00
17/05/2024 09:00
19/05/2024 07:00
18/05/2024 16:10
17/05/2024 16:43
18/05/2024 08:22